国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
17期
2543-2545
,共3页
无创通气%呼吸衰竭
無創通氣%呼吸衰竭
무창통기%호흡쇠갈
Noninvasive ventilation%Respiratory failure
目的 探讨无创通气治疗呼吸衰竭患者的疗效.方法 入选的90例患者均符合呼吸衰竭诊断标准,其中对照组45例,治疗组45例.对照组采用常规治疗方法,治疗组在常规治疗方法上加用无创通气.检测两组患者血PH值、动脉血氧分压(PaO2)、动脉二氧化碳分压( PaCO2)、心率、呼吸频率,统计住院时间、插管率及病死率.结果 治疗组在PH、PaO2、PaCO2、心率、呼吸频率的改善上均优于对照组(P＜0.05),治疗组住院天数少于对照组(P＜0.05),治疗组插管率明显低于对照组(P＜0.01),两组患者在死亡率上差异无统计学意义(P＞0.05).结论 无创通气具有无创、安全、治疗呼吸衰竭疗效确切等优点.
目的 探討無創通氣治療呼吸衰竭患者的療效.方法 入選的90例患者均符閤呼吸衰竭診斷標準,其中對照組45例,治療組45例.對照組採用常規治療方法,治療組在常規治療方法上加用無創通氣.檢測兩組患者血PH值、動脈血氧分壓(PaO2)、動脈二氧化碳分壓( PaCO2)、心率、呼吸頻率,統計住院時間、插管率及病死率.結果 治療組在PH、PaO2、PaCO2、心率、呼吸頻率的改善上均優于對照組(P＜0.05),治療組住院天數少于對照組(P＜0.05),治療組插管率明顯低于對照組(P＜0.01),兩組患者在死亡率上差異無統計學意義(P＞0.05).結論 無創通氣具有無創、安全、治療呼吸衰竭療效確切等優點.
목적 탐토무창통기치료호흡쇠갈환자적료효.방법 입선적90례환자균부합호흡쇠갈진단표준,기중대조조45례,치료조45례.대조조채용상규치료방법,치료조재상규치료방법상가용무창통기.검측량조환자혈PH치、동맥혈양분압(PaO2)、동맥이양화탄분압( PaCO2)、심솔、호흡빈솔,통계주원시간、삽관솔급병사솔.결과 치료조재PH、PaO2、PaCO2、심솔、호흡빈솔적개선상균우우대조조(P＜0.05),치료조주원천수소우대조조(P＜0.05),치료조삽관솔명현저우대조조(P＜0.01),량조환자재사망솔상차이무통계학의의(P＞0.05).결론 무창통기구유무창、안전、치료호흡쇠갈료효학절등우점.
Objective To explore the clinical efficacy of noninvasive ventilation ( NIV ) for respiratory failure.Methods 90 patients enrolled in this study all met the diagnostic criteria for respiratory failure; divide them into control group and study group,45 for each group.The control group received conventional treatment,while the study group received NIV in addition to the conventional treatment.PH,PaO2,PaCO2,HR,and RR were detected; length of hospital stay,intubation rate,and mortality rate were noted in both groups.Results The study group was superior to the control group in the improvement in PaO2,PaCO2,HR,and RR ( P＜ 0.05 ).Length of hospital stay was shorter in the study group than in the control group ( P＜ 0.05 ),and the intubation rate was lower in the study group ( P＜ 0.01 ).There was no significant difference in the mortality between the two groups ( P ＞ 0.05 ).Conclusions NIV is non-invasive,safe,and efficacious in the treatment of respiratory failure.
